Articles for category: Most Popular

Prediction: Quantum Computing Will Be the Biggest Theme in Artificial Intelligence (AI) in 2025. But Does That Mean You Should Invest in It?

Over the last couple of years, technology stocks have captivated the investment world thanks in large part to breakthroughs in artificial intelligence (AI). Within the AI realm, semiconductor stocks in particular have benefited greatly. This is due to the fact that semiconductor companies such as Nvidia, Advanced Micro Devices, and Broadcom make important infrastructure such ...

Notable Friday Option Activity: CVNA, TSLA, META

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Carvana Co (Symbol: CVNA), where a total volume of 189,331 contracts has been traded thus far today, a contract volume which is representative of approximately 18.9 million underlying shares (given that every 1 contract represents 100 underlying ...

Deadline Approaching: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Law Offices of Howard G. Smith reminds investors of the upcoming February 18, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) APLT securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). IF YOU ...

JEPQ, QBIG: Big ETF Inflows

Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the JPMorgan Nasdaq Equity Premium Income ETF, which added 8,400,000 units, or a 2.3% increase week over week. Among the largest underlying components of JEPQ, in morning trading today Apple is down about ...

3 Market Highs and Lows of 2024

I hope you enjoyed ringing in the New Year! Around this time, we look forward to the New Year, make any resolutions and see what might be in store for us. In fact, before the holidays, I chimed with a few predictions for 2025 of my own. You can read them here. But of course, ...

Johnson & Johnson's Quarterly Earnings Preview: What You Need to Know

Valued at a market cap of $348.2 billion, Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the healthcare field and operates through pharmaceuticals, medical devices, and consumer products divisions. The New Brunswick, New Jersey-based company has one of the largest research and development (R&D) budgets among pharma companies. It is scheduled ...